Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Pregnancy related complications and placenta pathology in pregnant women with sickle cell disease

Nneka Nwachukwu, Abraham Attah, Mohamad Ali Tfaily, Morgan McLemore, Fuad El Rassi

Blood (2025) 146 (Supplement 1): 4744.

https://doi.org/10.1182/blood-2025-4744

Published: 2025

Journal Articles

Correlation between outpatient opioid dosage and hospital visits in sickle cell disease patients

Elizabeth Minten, Kathryn Reynolds, Eldrida Randall, Fuad El Rassi, Morgan McLemore

Blood (2025) 146 (Supplement 1): 2962.

https://doi.org/10.1182/blood-2025-2962

Published: 2025

Journal Articles

Hemoglobin SC disease: Clinical analysis from the Georgia comprehensive sickle cell center at grady memorial hospital, Atlanta, Georgia.

Abraham Attah, Abisola Ajayi, Jhonsley Frederic, Fareedah Badmus, Dominique Mosley, Eldrida Randall, Tarun Aurora, Nneka Nwachukwu, Ross Fasano, Morgan McLemore, Fuad El Rassi

Blood (2025) 146 (Supplement 1): 6533.

https://doi.org/10.1182/blood-2025-6533

Published: 2025

Journal Articles

Feasibility of wearable technology for remote monitoring in high-risk adults with sickle cell disease: Baseline data from the SCD-carre trial

Charles Jonassaint, Alicia Colvin, Colleen Ballantyne, Marnie Bertolet, Jude Jonassaint, Carissa Low, Nirmish Shah, Ella Zadorozny, Fuad El Rassi, Santosh Saraf, Wally Smith, Maria Brooks, Darrell Triulzi, Mark Gladwin

Blood (2025) 146 (Supplement 1): 2600.

https://doi.org/10.1182/blood-2025-2600

Published: 2025

Journal Articles

A phase 2 open-label study of epeleuton in patients with sickle cell disease

Biree Andemariam, Vivien Sheehan, Fuad El Rassi, Moayed Hamza, Kirsty Kelly, John Climax

Blood (2025) 146 (Supplement 1): 4754.

https://doi.org/10.1182/blood-2025-4754

Published: 2025

Journal Articles

Chronic kidney disease risk stratification in compound sickle cell disease variants: A single center review

Abraham Attah, Jhonsley Frederic, Abisola Ajayi, Dominique Mosley, Fareedah Badmus, Dhikshitha Balaji, Maureen Njoku, Jeiran Razavi, Eldrida Randall, Ross Fasano, Nneka Nwachukwu, Morgan McLemore, Fuad El Rassi

Blood (2025) 146 (Supplement 1): 4730.

https://doi.org/10.1182/blood-2025-4730

Published: 2025

Journal Articles

Prophylactic transfusion in pregnant in women with sickle cell disease (ProTIP)

Abraham Attah, Hailly Butler, Fuad El Rassi, Ross Fasano, Morgan McLemore

Blood (2025) 146 (Supplement 1): 1371.

https://doi.org/10.1182/blood-2025-1371

Published: 2025

Journal Articles

Hemoglobin S beta thalessemia plus: Clinical analysis from the Georgia comprehensive sickle cell center at grady memorial hospital, Atlanta, Georgia.

Abraham Attah, Dhikshitha Balaji, Maureen Njoku, Jeiran Razavi, Eldrida Randall, Ross Fasano, Fuad El Rassi, Morgan McLemore

Blood (2025) 146 (Supplement 1): 411.

https://doi.org/10.1182/blood-2025-411

Published: 2025

Journal Articles

Sickle Pain-Related Impact (SPiRIt): A Prospective Study of Impact of Chronic Pain in Sickle Cell Disease

Ashna Jagtiani, Cynthia Sinha, Ashleigh Hawk, Scott Gillespie, Mona Mirbeyk, Fuad El Rassi, Wally R Smith, Lakshmanan Krishnamurti, Soumitri Sil, Nitya Bakshi

Blood (2024) 144 (Supplement 1): 3899.

https://doi.org/10.1182/blood-2024-210575

Published: 2024

Journal Articles

Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease

Julia Z Xu, Enrico M Novelli, Jean-Antoine Ribeil, Andreas Glenthøj, Srila Gopal, Hanny Al-Samkari, Modupe Idowu, Jenny Despotovic, Spurthi Patil, Xiaoshu Dai, Abdullah Al Masud, Michael Callaghan, Fuad El Rassi

Blood (2024) 144 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2024-203509

Published: 2024

Journal Articles

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Sophia Delicou, Fuad El Rassi, Biree Andemariam, Miguel R. Abboud, Julie Kanter, Marilyn J. Telen, Jessie Githanga, Adlette Inati, Ibrahim Idris, Sunil Navani, Eric Wu, Andrew Eisenberger

Blood (2024) 144 (Supplement 1): 179.

https://doi.org/10.1182/blood-2024-204962

Published: 2024

Journal Articles

Maternal and Fetal Outcomes in Sickle Cell Disease: Single Center Review

Abraham Attah, Mohamad Ali Tfaily, Morgan L. McLemore, Ross M. Fasano, Fuad El Rassi

Blood (2024) 144 (Supplement 1): 1126.

https://doi.org/10.1182/blood-2024-205507

Published: 2024

Journal Articles

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Danielle Cicka, Michelle L Schoettler, Morgan L. McLemore, Fuad El Rassi, Satheesh Chonat

Blood (2023) 142 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2023-191018

Published: 2023

Journal Articles

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Blood (2023) 142 (Supplement 1): 146.

https://doi.org/10.1182/blood-2023-179042

Published: 2023

Journal Articles

Inpatient Use of Extended-Release (ER) Opioids for Vaso-Occlusive Crisis Associated with Increased Length of Stay for ER Opioid-Naïve Patients

Madison Canning, Yi Liu, Shruti Gupta, Morgan L. McLemore, Fuad El Rassi

Blood (2023) 142 (Supplement 1): 2507.

https://doi.org/10.1182/blood-2023-179773

Published: 2023

Journal Articles

Rheological Characteristics of Elderly Individuals with Sickle Cell Disease Compared with an Adult Sickle Cell Population

Justin J Yoo, Jordan Zgodny, Britney Hernandez, Jawa Darazim, Ashwin P Patel, Fuad El Rassi, G. Karen Yu, Alka A Potdar, Vivien A. Sheehan

Blood (2023) 142 (Supplement 1): 926.

https://doi.org/10.1182/blood-2023-177791

Published: 2023

Journal Articles

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Carlton D. Dampier, Marilyn Jo Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves Pastore, Jennifer Rothman, James G. Taylor, VI, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell

Blood (2023) 141 (2): 168–179.

https://doi.org/10.1182/blood.2022015797

Published: 2023

Includes: Supplemental data

Journal Articles

Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)

Alan Anderson, Fuad El Rassi, Michael R. DeBaun, Modupe Idowu, Julie Kanter, Soheir Adam, Susanna Curtis, Darla Liles, Biree Andemariam, Morgan L. McLemore, Robert Sheppard Nickel, Poornima Ramadas, Jincy Paulose, Dramane I Laine, Mahmudul Khan, Deepika S. Darbari, Arthur L. Burnett

Blood (2022) 140 (Supplement 1): 1636–1638.

https://doi.org/10.1182/blood-2022-157004

Published: 2022

Journal Articles

COVID-19 Outcomes at a Comprehensive Sickle Cell Center: A Two-Year Report

Fuad El Rassi, Ross M. Fasano, Morgan L. McLemore

Blood (2022) 140 (Supplement 1): 8308–8309.

https://doi.org/10.1182/blood-2022-163482

Published: 2022

Journal Articles

The Mortality of Adult Sickle Cell Patients at a Comprehensive Sickle Cell Center

Jennifer A Afranie-Sakyi, Morgan L. McLemore, Fuad El Rassi

Blood (2021) 138 (Supplement 1): 971.

https://doi.org/10.1182/blood-2021-147463

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Pregnancy related complications and placenta pathology in pregnant women with sickle cell disease

Correlation between outpatient opioid dosage and hospital visits in sickle cell disease patients

Hemoglobin SC disease: Clinical analysis from the Georgia comprehensive sickle cell center at grady memorial hospital, Atlanta, Georgia.

Feasibility of wearable technology for remote monitoring in high-risk adults with sickle cell disease: Baseline data from the SCD-carre trial

A phase 2 open-label study of epeleuton in patients with sickle cell disease

Chronic kidney disease risk stratification in compound sickle cell disease variants: A single center review

Prophylactic transfusion in pregnant in women with sickle cell disease (ProTIP)

Hemoglobin S beta thalessemia plus: Clinical analysis from the Georgia comprehensive sickle cell center at grady memorial hospital, Atlanta, Georgia.

Sickle Pain-Related Impact (SPiRIt): A Prospective Study of Impact of Chronic Pain in Sickle Cell Disease

Results from a Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tebapivat (AG-946) in Patients with Sickle Cell Disease

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Maternal and Fetal Outcomes in Sickle Cell Disease: Single Center Review

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Primary Analysis of Spartan: A Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Patients with Sickle Cell Disease Related Priapism

Inpatient Use of Extended-Release (ER) Opioids for Vaso-Occlusive Crisis Associated with Increased Length of Stay for ER Opioid-Naïve Patients

Rheological Characteristics of Elderly Individuals with Sickle Cell Disease Compared with an Adult Sickle Cell Population

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Interim Analysis of a Phase 2 Trial to Assess the Efficacy and Safety of Crizanlizumab in Sickle Cell Disease Patients with Priapism (SPARTAN)

COVID-19 Outcomes at a Comprehensive Sickle Cell Center: A Two-Year Report

The Mortality of Adult Sickle Cell Patients at a Comprehensive Sickle Cell Center

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only